Data Fabrics in Pharma: Connecting Data for Better Decisions

Learn how a data fabric in pharma connects data for better decisions

Access the guide to explore the benefits of data fabrics in life sciences and see how a clinical data fabric (CDF) helps teams unify scientific and clinical data for faster, more confident decisions.

In drug development, critical evidence is often spread across clinical systems, lab platforms, study reports, regulatory documents, and scientific literature. This blog explains how a data fabric in pharma creates a governed, metadata-driven layer across structured and unstructured sources, without unnecessary data movement.

You’ll learn how a clinical data fabric supports secure cross-study discovery, stronger governance, and better AI readiness across the development lifecycle. The article also shows where a data fabric in life sciences fits alongside federated computing and AI-driven scientific workflows.

What you’ll learn:

What a data fabric in pharma is and why it matters in regulated environments

How a clinical data fabric (CDF) connects trials, documents, and research data

The benefits of data fabric in life sciences for search, governance, and reuse

How metadata and indexing support AI-driven scientific workflows

When federated computing complements a data fabric strategy

About the author

Sean McGee, MS

Director of Product, Certara

Sean McGee is currently the Director of Product at Certara, working within the Certara artificial intelligence (AI) group. Throughout his career, Mr. McGee has supported the strategy and go-to-market motions of various software technologies, including Benchling’s laboratory informatics platform and the AI and molecular modeling and simulation offerings for Dassault Systèmes BIOVIA brand. In his role with Certara, Mr. McGee guides the development of new AI-focused use cases which maximize the benefits of the Certara AI and broader company portfolio.

Download the guide

Complete the form to read the guide and learn how to connect siloed data for faster, better decisions across drug development.

About Certara

Certara is dedicated to transforming drug discovery and development for good. We harness the power of biosimulation, advanced analytics, and regulatory expertise to create a future where treatments reach patients faster and more efficiently.

From discovery to market access and commercial, we tailor solutions to meet our clients’ most pressing challenges. Through strategic leadership and advanced predictive technologies, Certara provides comprehensive solutions to optimize drug development processes, reduce risks, and improve outcomes. Our clients include more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 70 countries.